Search results
Author(s):
Roberto Galea
Added:
1 year ago
EHRA 2025 - Three-year findings comparing the Amplatzer Amulet (St. Jude Medical-Abbott) and Watchman/FLX (Boston Scientific) systems for left atrial appendage (LAA) occlusion show a trend towards a lower ischemic risk in the Amulet group compared with the Watchman/FLX group in terms of a composite of CV death, stroke, transient ischemic attack or systemic embolism.Dr Roberto Galea (Inselspital,…
View more
Author(s):
Walid Saliba
Added:
1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and…
View more
Author(s):
Saibal Kar
,
Harriette Van Spall
Added:
2 months ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk…
View more
AF Symposium 2025 Late-Breaking Science Collection
Video Series
Author(s):
Dhanunjaya Lakkireddy
Added:
1 year ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE …
View more
TransformAF Case Series
Start date:
May 06, 2025
Broadcast
Author(s):
Added:
1 month ago
Dr Amr Nawar (Sultan Qaboos University Hospital, Muscat, OM) walks through a concomitant pulmonary vein isolation (PVI) and left atrial appendage (LAA) closure procedure in a single 90-minute session — treating the arrhythmia and addressing embolic risk simultaneously.The case centres on a 70-year-old male with atrial fibrillation and a history of two transient ischaemic attacks. Dr Nawar details…
View more
Author(s):
Devi Nair
,
Vivek Reddy
Added:
2 months ago
ACC.26 - At ACC.26 in New Orleans, Dr Devi Nair (Arkansas, US) and Dr Vivek Reddy (New York, US) dissect the late-breaking CHAMPION‑AF trial, a large randomized comparison of first-line left atrial appendage closure with WATCHMAN FLX versus continued NOAC therapy in patients with non-valvular AF who can tolerate anticoagulation. They review the trial design, post‑implant antithrombotic and…
View more
Pugazhendhi Vijayaraman
Research Area(s) / Expertise:
Author
Robert Cubeddu, MD
Job title: Cardiologist
Author